CH513816A - Verfahren zur Herstellung von 2-(-2-(N-Acyloxy-N-acylamino)-acetamido)-phenyl-arylketonen - Google Patents

Verfahren zur Herstellung von 2-(-2-(N-Acyloxy-N-acylamino)-acetamido)-phenyl-arylketonen

Info

Publication number
CH513816A
CH513816A CH1257765A CH1257765A CH513816A CH 513816 A CH513816 A CH 513816A CH 1257765 A CH1257765 A CH 1257765A CH 1257765 A CH1257765 A CH 1257765A CH 513816 A CH513816 A CH 513816A
Authority
CH
Switzerland
Prior art keywords
acetamido
acylamino
acyloxy
phenyl
preparation
Prior art date
Application number
CH1257765A
Other languages
English (en)
Inventor
James Mccaully Ronald
Charles Bell Stanley
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of CH513816A publication Critical patent/CH513816A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH1257765A 1964-09-11 1965-09-09 Verfahren zur Herstellung von 2-(-2-(N-Acyloxy-N-acylamino)-acetamido)-phenyl-arylketonen CH513816A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39580764A 1964-09-11 1964-09-11
US46803065A 1965-06-29 1965-06-29

Publications (1)

Publication Number Publication Date
CH513816A true CH513816A (de) 1971-10-15

Family

ID=27015272

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1257765A CH513816A (de) 1964-09-11 1965-09-09 Verfahren zur Herstellung von 2-(-2-(N-Acyloxy-N-acylamino)-acetamido)-phenyl-arylketonen

Country Status (6)

Country Link
US (1) US3691235A (de)
CH (1) CH513816A (de)
DE (1) DE1493434A1 (de)
GB (2) GB1117613A (de)
IL (1) IL24185A (de)
NL (1) NL6511831A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972925A (en) * 1974-10-29 1976-08-03 Eli Lilly And Company N-perfluoroacyl-amino acids and derivatives thereof

Also Published As

Publication number Publication date
NL6511831A (de) 1966-03-14
GB1117613A (en) 1968-06-19
IL24185A (en) 1969-06-25
DE1493434A1 (de) 1970-06-11
US3691235A (en) 1972-09-12
GB1117614A (en) 1968-06-19

Similar Documents

Publication Publication Date Title
CH459982A (de) Verfahren zur Herstellung von Polyenketonen
CH448057A (de) Verfahren zur Herstellung von Phenylalkylaminoguanidinen
CH478779A (de) Verfahren zur Herstellung von a-Dithiosemicarbazonen
CH472353A (de) Verfahren zur Herstellung von Pyridin-4-thiolen
CH476717A (de) Verfahren zur Herstellung von Halogenribofuranosiden
CH467268A (de) Verfahren zur Herstellung von 5-Nitroimidazolen
CH440294A (de) Verfahren zur Herstellung von 4-Nitropyrazolen
CH478790A (de) Verfahren zur Herstellung von 7-Aminocumarinen
CH443528A (de) Verfahren zur Herstellung von 4-Brom-3-hydroxychinophthalon
CH473086A (de) Verfahren zur Herstellung von Acetylenaminen
CH447170A (de) Verfahren zur Herstellung von N-Alkyl-a-pyrrolidonen
CH473761A (de) Verfahren zur Herstellung von Dibenzocycloheptenylaminen
CH461473A (de) Verfahren zur Herstellung von Dibenzocycloheptenylaminen
CH478830A (de) Verfahren zur Herstellung von 3-Halogen-Thiadiazolen
CH513816A (de) Verfahren zur Herstellung von 2-(-2-(N-Acyloxy-N-acylamino)-acetamido)-phenyl-arylketonen
CH442336A (de) Verfahren zur Herstellung von o-Amino-benzonitrilen
CH475262A (de) Verfahren zur Herstellung von Pyrazin-4-oxyden
CH458378A (de) Verfahren zur Herstellung von N6-Methyltubercidin
CH465639A (de) Verfahren zur Herstellung von L-a-Niederalkyl-hydroxyphenylalaninen
CH471112A (de) Verfahren zur Herstellung von 4- Vinylchroman-4-olen
AT256812B (de) Verfahren zur Herstellung von Cyclopentano-ω-önanthlactam
CH443289A (de) Verfahren zur Herstellung von 17a-Äthoxy-6-chlor-6-dehydro-progesteron
CH450432A (de) Verfahren zur Herstellung von Bisaziridinen
CH460754A (de) Verfahren zur Herstellung von a-Acetyldigitoxin
CH453380A (de) Verfahren zur Herstellung von L-Tryptophanyl-L-methionyl-L-asparagyl-L-phenylalanimanid

Legal Events

Date Code Title Description
PL Patent ceased